Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...
About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, and 1 in 44 will die of the disease, according to the American Cancer Society (ACS). Fortunately, prostate cancer is ...
February is National Cancer Prevention Month and to help people keep life flowing smoothly, the Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), is ...
RIB MOUNTAIN, Wis. (WSAW) - About one in eight men will be diagnosed with prostate cancer during their lifetime, according to the American Cancer Society. The best way to be among the millions of ...
Prostate cancer is one of the most common and serious health issues affecting men worldwide. In its early stages, the symptoms are often subtle or easily overlooked — making early detection ...
Finasteride (Proscar), which inhibits conversion of testosterone to the more potent androgen dihydrotestosterone, reduces symptoms of benign prostatic hyperplasia (BPH). Because androgens promote the ...
Disclaimer: This is sponsored content. All opinions and views are of the advertiser and do not reflect the same of Fox 17. Prostate cancer is one of the most common cancers affecting men, affecting ...
Getty Images The American Cancer Society recommends that Black men discuss screening with their health care providers at age 45; the Prostate Cancer Foundation recommends prostate-specific antigen ...
To earn CME related to this news article, click here. February 25, 2009 — A new joint guideline produced by the American Society of Clinical Oncology (ASCO) and the American Urological Association ...
Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...
A major study of nearly 19,000 men has found that a baldness drug significantly cut the risk of prostate cancer, but its side effects may keep many from using it to prevent what has become the second ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...